Welcome to our dedicated page for SMITH & WESSON BRANDS SEC filings (Ticker: SWBI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Smith & Wesson Brands, Inc. filings document the regulatory record for a Nevada firearm manufacturer whose common stock trades as SWBI on the Nasdaq Global Select Market.
Recent disclosures include Form 8-K reports furnishing operating results and financial condition updates, proxy materials covering director elections, advisory executive-compensation votes and auditor ratification, and material-agreement filings for amendments to the company's credit agreement. The filings also identify the registered common stock class and provide formal records of governance votes, capital-structure terms, lender arrangements, and financial-performance disclosures tied to the firearms business.
SMITH & WESSON BRANDS, INC. officer Kevin Alden reported routine equity compensation and related tax withholding transactions in the company’s common stock.
On May 1, 2026, he received an award of 27,612 shares of common stock at no cost and was granted 55,222 performance rights, each representing a contingent right to receive one share of common stock based on stock price performance over a three-year period. The filing notes that one-fourth of related restricted stock units vest on each of the first four anniversaries of the grant date, with shares delivered net of tax withholding.
To cover tax obligations related to vesting restricted stock units, the issuer withheld 6,854 shares of common stock on May 1, 2026 and 653 shares on May 2, 2026. These tax-withholding dispositions were not open-market sales. After these transactions, Alden directly held 121,635 shares of common stock and 55,222 performance rights.
SMITH & WESSON BRANDS, INC. officer Deana L. McPherson reported equity compensation awards and related tax withholding entries. On May 1, 2026, she received 27,612 shares of common stock at no cost as a grant or award.
She was also granted 55,222 performance rights, each contingently convertible into one share of common stock based on stock price performance over three years, with an expiration date of May 1, 2029. To satisfy tax withholding obligations tied to vesting restricted stock units, the issuer withheld 6,660 shares on May 1, 2026 at $15.57 per share and 880 shares on May 2, 2026 at $14.97 per share. After these transactions, she directly holds 158,754 common shares.
Smith & Wesson Brands Inc: The Vanguard Group filed an amendment on a Schedule 13G/A reporting zero shares beneficially owned of Smith & Wesson Brands Inc Common Stock following an internal realignment. The filing states certain Vanguard subsidiaries will report ownership separately in reliance on SEC Release No. 34-39538 (January 12, 1998).
The amendment discloses Amount beneficially owned: 0 and Percent of class: 0%, and is signed by Ashley Grim as Head of Global Fund Administration on 03/27/2026.
Smith & Wesson Brands, Inc. reported stronger quarterly results while year-to-date profit declined. For the three months ended January 31, 2026, net sales rose to $135.7 million from $115.9 million, driven mainly by a 34.6% increase in handgun revenue and a shift toward higher-priced new models and a 2%–3% price increase on select products. Gross margin improved to 26.2% from 24.1%, helped by better fixed-cost absorption, lower promotions, and lower federal firearms excise taxes, partly offset by higher tariffs and labor costs. Quarterly net income increased to $3.8 million, or $0.08 per diluted share, compared with $2.1 million, or $0.05 per diluted share.
Over the nine months, net sales grew modestly to $345.5 million from $333.9 million, while net income fell to $2.3 million, or $0.05 per diluted share, versus $4.8 million, or $0.11 per diluted share, as operating margin narrowed to 2.3%. Long gun sales declined 25.8% and other products and services revenue decreased 15.9%, reflecting softer demand and lower business-to-business, parts, and suppressor sales. Inventory was reduced to $175.3 million from $189.8 million through proactive production planning. As of January 31, 2026, cash and cash equivalents were $18.4 million, marketable securities were $5.0 million, total assets were $538.0 million, and total borrowings on the revolving credit line were $75.0 million at a 5.75% weighted average interest rate. Stockholders’ equity stood at $363.4 million after ongoing dividends and the retirement of 31.7 million treasury shares.
Smith & Wesson Brands, Inc. reported stronger third quarter fiscal 2026 results for the period ended January 31, 2026. Net sales were $135,709,000, up from $115,885,000 a year earlier, and net income increased to $3,753,000 from $2,102,000. Diluted earnings per share rose to $0.08 from $0.05.
Management highlighted particularly strong handgun performance, with unit shipments into the sporting goods channel up 28% while NICS background checks declined 2.2%, indicating market share gains. The company expects fourth quarter fiscal 2026 sales to be 10–12% higher than the fiscal 2025 fourth quarter.
Operating cash flow for the nine months ended January 31, 2026 improved to $39,614,000 from negative $48,051,000, and free cash flow turned positive to $20,700,000. Consistent with its capital allocation strategy, the board authorized a quarterly dividend of $0.13 per share, payable April 2, 2026 to stockholders of record on March 19, 2026.
Renaissance Technologies LLC and Renaissance Technologies Holdings Corporation report beneficial ownership of 2,196,874 shares of Smith & Wesson Brands, Inc. common stock, representing 4.94% of the class as of 12/31/2025. They have sole voting and dispositive power over these shares and no shared power.
The filing states the position is held in the ordinary course of business and not for the purpose of changing or influencing control of Smith & Wesson. Certain funds managed by Renaissance Technologies LLC have the right to receive dividends and sale proceeds from these shares.
Dimensional Fund Advisors LP filed an amended Schedule 13G reporting beneficial ownership of 2,473,250 shares of Smith & Wesson Brands Inc common stock, representing 5.6% of the class.
Dimensional has sole voting power over 2,424,631 shares and sole dispositive power over all 2,473,250 shares, while the shares are owned by investment funds it advises and it disclaims beneficial ownership beyond Section 13(d) purposes. Dimensional certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Smith & Wesson Brands.
Smith & Wesson Brands, Inc. (SWBI) reported an insider ownership update via a Form 3. The company’s Vice President, Marketing is shown as beneficially owning 140,620 shares of common stock as of the event date 09/15/2025.
The total includes restricted stock units scheduled to vest over time: 5,333 RSUs (grant 06/15/2022, vest at year 4); 12,788 RSUs (grant 06/15/2023, vest 50% at years 3 and 4); 23,437 RSUs (grant 06/15/2024, vest 33% at years 2–4); and 35,680 RSUs (grant 06/15/2025, vest 33% at years 1–3).
Michelle Lohmeier, a director of Smith & Wesson Brands, Inc. (SWBI), reported an acquisition of 12,711 shares of common stock via restricted stock units on 09/15/2025. The reported transaction shows a $0 price per share because the shares were granted as RSUs, and Lohmeier's beneficial ownership following the grant is 38,161 shares held directly. The RSUs vest 1/12th on the 15th day of each month after grant, with 100% of vested shares to be delivered on the one-year anniversary of the grant. The Form 4 was signed by an attorney-in-fact on 09/17/2025.
Denis G. Suggs, a director of Smith & Wesson Brands, Inc. (SWBI), was granted 12,711 restricted stock units on 09/15/2025. The award was reported as an acquisition at a $0 price and increases his beneficial ownership to 48,315 shares following the grant. The restricted stock units vest monthly at a rate of 1/12th on the 15th day of each month after the grant date, with 100% of vested shares to be delivered on the one-year anniversary of the grant. The Form 4 was signed by an attorney-in-fact on 09/17/2025.